Picture of AxoGen logo

AXGN — AxoGen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

AxoGen Inc reports results for the quarter ended in June - Earnings Summary

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue rose 10.7% to $38.16 million from a year ago;
analysts
expected $39.08 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 16
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AxoGen Inc shares had fallen by 7.8% this quarter and
lost 15.6%
so far this year.
    * The company reported a quarterly loss of $6.66 million.
    * Wall Street's median 12-month price target for AxoGen Inc
is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.13          -0.03          Beat
 Mar. 31 2023      -0.14          -0.10          Beat
 Dec. 31 2022      -0.11          -0.03          Beat
 Sep. 30 2022      -0.12          -0.01          Beat

Recent news on AxoGen

See all news